REGULATORY INTELLIGENCE
Cybersecurity as a Compliance Requirement in Connected Devices
From an era where cybersecurity was largely an IT concern to one where it is a core regulatory obligation, connected devices have triggered a profound reorientation in how regulators and manufacturers view safety, efficacy, and market suitability. Regulatory affairs professionals must now translate technical security practices into demonstrable, auditable compliance artifacts — embedding risk management, supplier governance, and lifecycle controls into the product's regulatory strategy.
Cybersecurity as a Material Characteristic of Device Conformity
For connected devices, cybersecurity is material to both safety and intended function. A compromised device can fail to perform its clinical function or create hazardous states for users and environments. Regulators increasingly treat security-related vulnerabilities as safety issues — a successful exploit may lead directly to harm or to loss of availability that jeopardizes patient care.
Cybersecurity controls are no longer optional. They are material attributes that must be identified, risk-assessed, verified, documented, and reported to competent authorities throughout the product lifecycle.
Global Regulatory Landscape
A clear trend has emerged toward prescriptive and enforceable requirements. Key regulatory developments include:
FDA premarket and postmarket cybersecurity guidance requiring formal threat modeling and vulnerability management
EU product safety regime and cybersecurity proposals broadening manufacturer obligations
UK Product Security and Telecommunications Infrastructure legislation imposing mandatory security requirements
NIS2 Directive extending obligations to operators of essential services and critical digital providers
Standards have become critical reference points: ETSI EN 303 645, ISO/IEC 27001, IEC 62443, and NIST's Cybersecurity Framework are increasingly cited by regulators and procurement authorities.
Operationalizing Cybersecurity Compliance
For RA professionals, the central challenge is converting cybersecurity expectations into compliant, defensible artifacts within regulatory submissions, technical files, and postmarket surveillance. This requires clear, traceable documentation of cybersecurity risk assessment, design controls, verification and validation activities, and postmarket vulnerability management.
Key requirement — SBOM Software Bill of Materials (SBOM) requirements are now expected in FDA premarket submissions for connected devices. Manufacturers must document all software components — including third-party libraries — and maintain that inventory through the product lifecycle.
Postmarket Vigilance and Vulnerability Management
Postmarket cybersecurity obligations have grown substantially. Manufacturers must implement processes for monitoring reported vulnerabilities, assessing clinical impact, and communicating with regulators and customers in a timely manner. Coordinated vulnerability disclosure programs and structured patch processes are now expected features of a mature device security program.
Practical Steps for RA Professionals
Integrate cybersecurity risk management with ISO 14971 processes from product inception
Establish cross-functional security governance with defined accountabilities
Build and maintain a Software Bill of Materials for all connected device products
Implement a coordinated vulnerability disclosure program and postmarket monitoring process
Map cybersecurity controls to specific regulatory submission requirements by jurisdiction